
Don't Think Too Hard About Gum
At the turn of the 20th century, William Wrigley Jr. was bent on building an empire of gum, and as part of his extensive hustle, he managed to persuade the U.S. Department of War to include his products in soldiers' rations. His argument—baseless at the time—was that chewing gum had miraculous abilities to quench thirst, stave off hunger, and dissipate nervous tension. But he was right: Scientists have since found that gum chewing can indeed increase concentration, reduce the impulse to snack, alleviate thirst, and improve oral health.
Perhaps that's why people around the world have had the impulse to gnaw on tacky materials—roots, resins, twigs, blubber, tar made by burning birch bark—for at least 8,000 years. Today, gum is again being marketed as a panacea for wellness. You can buy gum designed to deliver energy, nutrition, stress relief, or joint health; scientists are even developing gums that can protect against influenza, herpes, and COVID. Ironically, this new era of chewing gum is manufactured with a distinctly modern ingredient, one not usually associated with wellness: plastic.
By the time Wrigley began his business venture, Americans had grown accustomed to chewing gum sold as candy-coated balls or packaged sticks. The base of these chewing gums was made from natural substances such as spruce resin and chicle, a natural latex that Aztecs and Mayans chewed for hundreds if not thousands of years. Unfortunately for 20th-century Americans, the chicozapote trees that exude chicle take a long time to grow, and if they are overtapped, they die. Plus, cultivated trees don't produce nearly as much chicle as wild trees, says Jennifer Mathews, an anthropology professor at Trinity University and the author of Chicle. In the 1950s, chicle harvesters began struggling to meet demand. So gum companies turned to the newest innovations in materials science: synthetic rubbers and plastics.
Today, most companies' gum base is a proprietary blend of synthetic and natural ingredients: If a packet lists 'gum base' as an ingredient, that gum most likely contains synthetic polymers. The FDA allows gum base to contain any of dozens of approved food-grade materials—substances deemed either safe for human consumption or safe to be in contact with food. Many, though, are not substances that people would otherwise think to put in their mouth. They include polyethylene (the most common type of plastic, used in plastic bags and milk jugs), polyvinyl acetate (a plastic also found in glue), and styrene-butadiene rubber (commonly used in car tires). The typical gum base contains two to four types of synthetic plastics or rubbers, Gwendolyn Graff, a confectionery consultant, told me.
Everything we love about gum today is thanks to synthetic polymers, Graff said. Polyvinyl acetate, for example, strengthens the bubble film. 'If you blow a bubble, and it starts to get holes in it and deflate, that's usually an indicator that it doesn't have polyvinyl acetate,' Graff said. Styrene-butadiene rubber creates a bouncy chewiness that makes gum more likely to stick to itself rather than to surfaces like your teeth. Polyethylene can be used to soften gum so it doesn't tire out your jaw. Gums with only natural polymers 'can feel like they're going to fall apart in your mouth,' Graff said.
Plastic gum, though, also falls apart, in a way: Gum chewing has been linked to microplastic ingestion. In a study published in December, U.K. researchers had a volunteer chew on a piece of gum for an hour, spitting into test tubes as they went. After an hour of gum chewing, the saliva collected contained more than 250,000 pieces of micro and nano plastics—comparable to the level of microplastics found in a liter of bottled water. In a study presented at a recent meeting of the American Chemical Society (which has not yet been peer-reviewed), a graduate student's saliva contained elevated microplastic levels after she chewed several commercially available gums, including natural ones. The research on gum chewing and microplastics is still limited—these two papers effectively represent analysis of just two people's post-chew saliva—but gum chewing has also been correlated with higher urine levels of phthalates, plastic-softening chemicals that are known endocrine disruptors.
Scientists are still learning about the health impacts of microplastic ingestion, too. Microplastics find their way into all kinds of foods from packaging or contamination during manufacturing, or because the plants and animals we eat absorb and ingest microplastics themselves. As a result, microplastics have been found in human livers, kidneys, brains, lungs, intestines, placentas, and breast milk, but exactly how our bodies absorb, disperse, and excrete ingested plastic is not very well studied, says Marcus Garcia, who researches the health effects of environmental contaminants at the University of New Mexico. Some research in mice and cultured cells hint that microplastics have the potential to cause damage, and epidemiological research suggests that microplastics are associated with respiratory, digestive, and reproductive issues, as well as colon and lung cancer. But scientists are still trying to understand whether or how microplastics cause disease, which microplastics are most dangerous to human health, and how much microplastic the body can take before seeing any negative effects.
The answer could affect the future of what we choose to eat—or chew. Ingesting tiny plastic particles might seem inevitable, but over the past 10 years or so, Americans have grown understandably fearful about bits of plastic making their way into our food, fretting about microwaving food in plastic containers and drinking from plastic bottles. Gum has, for the most part, not triggered those worries, but in recent years, its popularity had been dropping for other reasons. In a bid to reverse that trend, gum companies are marketing synthetic gum as a tool for wellness. Just like Wrigley, they are betting that Americans will believe in the power of gum to soothe nerves and heal ailments, and that they won't think too hard about what modern gum really is. For anyone worried about swallowing still more plastic, after all, gum is easy enough to avoid.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration


Washington Post
an hour ago
- Washington Post
Salmonella outbreak tied to eggs sickens dozens across 7 states
A salmonella outbreak linked to a large egg recall has made dozens of people sick in seven states in the West and Midwest, federal health officials said Saturday. The August Egg Company recalled about 1.7 million brown organic and brown cage-free egg varieties distributed to grocery stores between February and May because of the potential for salmonella, according to a posted announcement Friday on the Food and Drug Administration's website. At least 79 people in seven states have gotten a strain of salmonella that was linked to the eggs, and 21 people have been hospitalized. the U.S. Centers for Disease Control and Prevention said. The recall covers Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington and Wyoming. A list of brands and plant codes or Julian dates can be found on the FDA and CDC websites. Symptoms of salmonella poisoning include diarrhea, fever, severe vomiting, dehydration and stomach cramps. Most people who get sick recover within a week. Infections can be severe in young children, older adults and people with weakened immune systems, who may require hospitalization. The CDC advises people to throw away recalled eggs or return them to the store where they were purchased. Consumers should also wash and disinfect any surfaces that came in contact with the eggs. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Yahoo
an hour ago
- Yahoo
Botulism cases linked to Botox injections under investigation in Massachusetts
Massachusetts health officials are investigating four recent cases of suspected botulism connected to cosmetic injections of Botox. The outbreak on the South Shore prompted the Department of Public Health to warn health care providers to be alert about symptoms. consistent with botulism occurring after botulinum toxin injections. Botox is widely used for cosmetic purposes to reduce wrinkles and fine lines. 'While generally safe when administered by trained professionals, improper dosing, administration technique, or use of non-FDA-approved products may increase the risk of systemic botulism symptoms,' the DPH advisory said. Botulism, though rare, can be fatal. It occurs when botulinum toxin enters the bloodstream and can produce effects far from the injection site, according to the advisory. Initial botulism symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing and breathing problems, according to state health officials. These symptoms may progress to muscle weakness that worsens over hours to days. Anybody who is experiencing any symptoms should go to an emergency room. 'This is very rare,' South Shore Hospital infectious disease specialist Dr. Todd Ellerin told WCVB. 'We call it iatrogenic botulism, which means you get it as a complication of an injection. It is very rare.' The DPH has not released details about the condition of the four individuals involved in the South Shore cases or information about the provider or facility where they received their injections. How pink heart shaped fentanyl led to Mass. father's 18-year prison sentence ICE deportation blocked by Boston judge: Migrants now in shipping container in Djibouti Mass. State Lottery winner: Father will take children to Disney with $100K prize Former police deputy chief, school resource officer convicted of child rape Mass. casino winner: $2.50 bet won gambler jackpot prize ``` Read the original article on MassLive.